Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Youn, Su‐Hyung Park, Dimitri Lavillette, F. Cosset, Se‐Hwan Yang, Chang Lee, H. Jin, Chang‐Min Kim, M. Shata, Dong‐Hun Lee, W. Pfahler, A. Prince, Y. Sung (2005)
Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzeeHepatology, 42
Stephen Chen, T. Morgan (2006)
The Natural History of Hepatitis C Virus (HCV) InfectionInternational Journal of Medical Sciences, 3
P. Pileri, Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi, R. Petracca, A. Weiner, M. Houghton, D. Rosa, G. Grandi, S. Abrignani (1998)
Binding of hepatitis C virus to CD81.Science, 282 5390
M. Ardo, D. Ulver, C. Iesielski, P. Amela, R. Arcus, D. Biteboul, J. Eptonstall, F. Ot, P. Ibben, D. Ell (2009)
A Case–Control Study of HIV Seroconversion in Health Care Workers after Percutaneous Exposure, 12
M. Winters, Aarthi Chary, Robert Eison, D. Asmuth, M. Holodniy (2010)
Impact of highly active antiretroviral therapy on hepatitis C virus protease quasispecies diversity in HIV co‐infected patientsJournal of Medical Virology, 82
C. Rollier, G. Paranhos-Baccalà, E. Verschoor, B. Verstrepen, J. Drexhage, Z. Fagrouch, J. Berland, F. Komurian-Pradel, Blandine Duverger, Nourrédine Himoudi, C. Staib, Marcus Meyr, M. Whelan, J. Whelan, Victoria Adams, E. Larrea, J. Riezu, J. Lasarte, B. Bartosch, F. Cosset, W. Spaan, H. Diepolder, G. Pape, G. Sutter, G. Inchauspe, J. Heeney (2007)
Vaccine‐induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD‐1 and chronicityHepatology, 45
Y. Benhamou, V. Martino, M. Bochet, G. Colombet, V. Thibault, A. Liou, C. Katlama, T. Poynard (2001)
Factors affecting liver fibrosis in human immunodeficiency virus–and hepatitis C virus–coinfected patients: Impact of protease inhibitor therapyHepatology, 34
B. Gilliam, R. Redfield (2005)
Approaches to antiretroviral therapy in ChinaCell Research, 15
E. Scarselli, H. Ansuini, R. Cerino, R. Roccasecca, S. Acali, G. Filocamo, C. Traboni, A. Nicosia, R. Cortese, A. Vitelli (2002)
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virusThe EMBO Journal, 21
G. Elmowalid, M. Qiao, S. Jeong, B. Borg, T. Baumert, Ronda Sapp, Zongyi Hu, K. Murthy, T. Liang (2007)
Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzeesProceedings of the National Academy of Sciences, 104
Q. Choo, K. Richman, Jang Han, K. Berger, C. Lee, Christine Dong, C. Gallegos, D. Coit, R. Medina-Selby, P. Barr (1991)
Genetic organization and diversity of the hepatitis C virus.Proceedings of the National Academy of Sciences of the United States of America, 88
S. Hammer, J. Eron, P. Reiss, R. Schooley, M. Thompson, S. Walmsley, P. Cahn, M. Fischl, J. Gatell, M. Hirsch, D. Jacobsen, J. Montaner, D. Richman, P. Yeni, P. Volberding (2008)
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.JAMA, 300 5
D. Strader, T. Wright, David Thomas, L. Seeff (2004)
Diagnosis, management, and treatment of hepatitis CHepatology, 39
M. Sulkowski, David Thomas (2003)
Hepatitis C in the HIV-Infected PersonAnnals of Internal Medicine, 138
M. Thompson, J. Aberg, P. Cahn, J. Montaner, G. Rizzardini, A. Telenti, J. Gatell, H. Günthard, S. Hammer, M. Hirsch, D. Jacobsen, P. Reiss, D. Richman, P. Volberding, P. Yeni, R. Schooley (2008)
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.JAMA, 304 3
D. Lavanchy (1999)
Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium.Journal of viral hepatitis, 6 1
J. Youn, Yu-Wen Hu, N. Tricoche, W. Pfahler, M. Shata, M. Dreux, F. Cosset, A. Folgori, Dong‐Hun Lee, B. Brotman, A. Prince (2008)
Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia VirusJournal of Virology, 82
Amy WEINERt, H. Geysen, Cindy CHRISTOPHERSONt, J. HALLt, T. Mason, Giorgio, Saraccoi, F. Bonino, Kevin CRAWFORDt, D. Christopher, MARIONt, Kenneth CRAWFORDt, Maurizia, Brunetto, Philip BARRt, T. Miyamura, John MCHUTCHINSONtt, Michael HOUGHTONtt (1992)
Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections.Proceedings of the National Academy of Sciences of the United States of America, 89
Maurizio Bonacini, Massimo Puoti (2000)
Hepatitis C in patients with human immunodeficiency virus infection: diagnosis, natural history, meta-analysis of sexual and vertical transmission, and therapeutic issues.Archives of internal medicine, 160 22
S. Hammer, J. Eron, P. Reiss, R. Schooley, M. Thompson, S. Walmsley, P. Cahn, M. Fischl, J. Gatell, M. Hirsch, D. Jacobsen, J. Montaner, D. Richman (2008)
Antiretroviral Treatment of Adult HIV Infection 2008 Recommendations of the International AIDS Society–USA Panel
T. Shen, Xiangmei Chen, Weidong Zhang, Y. Xi, G. Cao, Y. Zhi, Shuiwang Wang, Chunhui Xu, Lai Wei, F. Lu, H. Zhuang (2011)
A Higher Correlation of HCV Core Antigen with CD4+ T Cell Counts Compared with HCV RNA in HCV/HIV-1 Coinfected PatientsPLoS ONE, 6
N. Kato, Y. Ootsuyama, H. Sekiya, S. Ohkoshi, T. Nakazawa, M. Hijikata, K. Shimotohno (1994)
Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infectionJournal of Virology, 68
D. Lavanchy, R. Purcell, F. Hollinger, C. Howard, A. Alberti, M. Kew, G. Dusheiko, M. Alter, E. Ayoola, P. Beutels, R. Bloomer, B. Ferret, R. Decker, R. Esteban, O. Fay, H. Fields, E. Fuller, P. Grob, M. Houghton, N. Leung, S. Locarnini, H. Margolis, A. Meheus, T. Miyamura, M. Mohamed, B. Tandon, D. Thomas, H. Head, A. Toukan, P. Damme, A. Zanetti, R. Arthur, M. Couper, R. Amelio, J. Emmanuel, K. Esteves, P. Gavinio, E. Griffiths, Z. Hallaj, C. Heuck, D. Heymann, S. Holck, M. Kane, L. Martinez, F. Meslin, I. Mochny, A. Ndikuyeze, A. Padilla, G. Rodier, C. Roure, F. Savage, G. Vercauteren (1999)
Global surveillance and control of hepatitis CJournal of Viral Hepatitis, 6
M. Winters, S. Welles, M. Holodniy (2006)
Hepatitis C Virus Protease Gene Diversity in Patients Coinfected with Human Immunodeficiency VirusJournal of Virology, 80
D. Cardo, D. Culver, C. Ciesielski, P. Srivastava, R. Marcus, D. Abiteboul, J. Heptonstall, G. Ippolito, F. Lot, P. McKibben, D. Bell (1997)
A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group.The New England journal of medicine, 337 21
S. Villano, D. Vlahov, K. Nelson, S. Cohn, David Thomas (1999)
Persistence of viremia and the importance of long‐term follow‐up after acute hepatitis C infectionHepatology, 29
F. Nevens, T. Roskams, H. Vlierberghe, Y. Horsmans, D. Sprengers, A. Elewaut, V. Desmet, G. Leroux-Roels, E. Quinaux, E. Depla, S. Dincq, C. Stichele, G. Maertens, F. Hulstaert (2003)
A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis CHepatology, 38
M. Danta, N. Semmo, P. Fabris, David Brown, O. Pybus, C. Sabin, S. Bhagani, V. Emery, G. Dusheiko, P. Klenerman (2008)
Impact of HIV on host-virus interactions during early hepatitis C virus infection.The Journal of infectious diseases, 197 11
M. Evans, T. Hahn, Donna Tscherne, A. Syder, M. Panis, B. Wölk, T. Hatziioannou, J. McKeating, P. Bieniasz, C. Rice (2007)
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entryNature, 446
V. Re, J. Kostman, V. Amorosa (2008)
Management complexities of HIV/hepatitis C virus coinfection in the twenty-first century.Clinics in liver disease, 12 3
G. Leroux-Roels, E. Depla, F. Hulstaert, L. Tobback, S. Dincq, Jaques Desmet, I. Desombere, G. Maertens (2004)
A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers.Vaccine, 22 23-24
Coinfection with HCV and HIV is prevalent among former commercial blood donors in some rural areas in China. Genetic variability of the HCV core and E1/HVR1 was investigated in 23 patients chronically infected with HCV-1b, with or without concomitant HIV infection. Genetic variability in the core sequence was higher under HIV-associated immunocompromised conditions. Both the Shannon entropy values at each nucleotide position and the dN/dS values at each codon were statistically higher in HIV/HCV-coinfected patients with lower CD4+ T cell counts (p-values were <0.0001 and equal to 0.0372, respectively). The more significant difference of dN/dS value occurred in a specific subregion of the core gene that is enriched in CTL/Th epitopes (p = 0.0083). The dN/dS values of full-length core antigen were found to be negatively correlated with the S/CO ratio of plasma anti-HCV antibodies. By contrast, no significant difference in genetic diversity/complexity and dN/dS values in the E1/HVR1 region was found between those two groups. These results suggest that the dN/dS ratio in the core gene, but not in the E1/HVR1 gene, is influenced more by host CD4+ T cell–mediated cellular immunity.
Archives of Virology – Springer Journals
Published: Nov 1, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.